The Onpattro Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Onpattro market has experienced a historical compound annual growth rate (HCAGR) of XX. The market size is projected to increase from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%.
The Onpattro market is projected to reach $XX million by 2029, growing at a compound annual growth rate (CAGR) of XX%.
Download Your Free Sample of the 2025 Onpattro Market Report and Uncover Key Trends Now!Key growth drivers of the onpattro market include:
• Increased prevalence of diabetes worldwide
• Rising rates of obesity and sedentary lifestyles
• Poor dietary habits contributing to diabetes
• Effective management and treatment outcomes due to Onpattro technology
The onpattro market covered in this report is segmented –
1) By Clinical Indication: Hereditary Transthyretin-Mediated Amyloidosis, Wild-Type Transthyretin Amyloidosis, Other Transthyretin-Related Amyloidoses
2) By Distribution Channel: Direct Sales, Pharmacies, Online Pharmacies
3) By End User: Hospitals, Specialty Clinics, Home Healthcare Providers
Market trends in the onpattro market include:
• The market is being characterized by a growing adoption of ribonucleic acid-based therapies.
• There's an increase in the number of Orphan Drug Designations.
• The integration of digital health tools in onpattro treatment is becoming more popular.
• There is a noted shift toward personalized medicine and advanced drug delivery technologies.
The top competitors and leading players in the onpattro market are:
• Novo Nordisk A/S
North America was the largest region in the onpattro market in 2024